1-20 of 39
Claudia Cellini
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Predictors of unsustained measurable residual disease negativity in patients with multiple myeloma

Clinical Trials & Observations Brief Report
Mattia D’Agostino, Giuseppe Bertuglia, Delia Rota-Scalabrini, Angelo Belotti, Sonia Morè, Paolo Corradini, Stefania Oliva, Antonio Ledda, Mariella Grasso, Vincenzo Pavone, Sonia Ronconi, Iolanda Donatella Vincelli, Stelvio Ballanti, Cristina Velluti, Claudia Cellini, Alessandro Gozzetti, Angelo D. Palmas, Barbara Gamberi, Katia Mancuso, Laura Paris, Renato Zambello, Maria Teresa Petrucci, Benedetto Bruno, Pellegrino Musto, Francesca Gay
Journal: Blood
Blood (2024) 143 (7): 592–596.
https://doi.org/10.1182/blood.2023022080
Published: 2024
Includes: Supplemental data
Journal Articles

Late Hematologic Recovery after CPX-351 Induction Chemotherapy in AML: Predictive Disease and Patient's Factors and Their Impact on Survival

Michela Rondoni, Paola Minetto, Bruna Puglisi, Francesco Saraceni, Lorenzo Brunetti, Anna Maria Mianulli, Monica Bocchia, Adele Santoni, Carola Riva, Barbara Giannini, Federica Monaco, Beatrice Zannetti, Claudia Cellini, Annalisa Nicoletti, Anna Maria Valenti, Debora Capelli, Donatella Raspadori, Attilio Olivieri, Francesco Lanza, Claudio Graziano, Patrizia Tosi, Roberto Massimo Lemoli, Fabio Guolo
Journal: Blood
Blood (2023) 142 (Supplement 1): 4275.
https://doi.org/10.1182/blood-2023-182993
Published: 2023
Journal Articles

Survival Patterns of Non-Randomized Patients in the IELSG37 Study: Deauville Score 4 Is Not Necessarily Associated with Poor Outcome in Primary Mediastinal Lymphoma

Emanuele Zucca, Luca Ceriani, Andrew S. Davies, Giovannino Ciccone, Umberto Ricardi, Alice Di Rocco, Iryna Kryachok, Barbara Botto, Monica Balzarotti, Alessandra Tucci, Vittorio Ruggero Zilioli, Sara Usai, Luca Arcaini, Elsa Pennese, Anna Dabrowska-Iwanicka, Andrés José María Ferreri, Franceso Merli, Wei Li Zhao, David Hodgson, Codruta Ionescu, Luigi Rigacci, Claudia Cellini, Caterina Stelitano, Stefano Volpetti, Carla Minoia, Michele Spina, Alexander Fossa, George Mikhaeel, Kate Cwynarski, Andrea Janikova, Yana Stepanishyna, Mats Jerkeman, Andreas Huettmann, Maria Gomes da Silva, Don A. Stevens, Sally F Barrington, Bogdan Małkowski, Ur Metser, Annibale Versari, Stephane Chauvie, Oreste Bagni, Kelly Cozens, Sonia Perticone, Nicoletta Ielmini, Letizia Deantonio, Jan Walewski, Marek Trneny, Mary Gospodarowicz, Franco Cavalli, Peter Johnson, Maurizio Martelli
Journal: Blood
Blood (2023) 142 (Supplement 1): 1718.
https://doi.org/10.1182/blood-2023-174093
Published: 2023
Journal Articles

Carfilzomib-Lenalidomide-Dexamethasone (KRd) Vs. Lenalidomide-Dexamethasone (Rd) in Newly Diagnosed Fit or Intermediate-Fit Multiple Myeloma Patients Not Eligible for Autologous Stem-Cell Transplantation (Phase III EMN20 Trial): Analysis of Sustained Undetectable Minimal Residual Disease (MRD)

Sara Bringhen, Elisabetta Antonioli, Barbara Gamberi, Benedetto Bruno, Daniele Derudas, Patrizia Tosi, Francesca Fazio, Rita Mazza, Sonia Ronconi, Paolo Corradini, Flavia Lotti, Claudia Cellini, Antonietta Pia Falcone, Piero Galieni, Roberto Ria, Angelo Belotti, Donato Mannina, Anna Maria Cafro, Clotilde Cangialosi, Iolanda Donatella Vincelli, Alessandra Lombardo, Alessandra Larocca, Mario Boccadoro, Mattia D'Agostino
Journal: Blood
Blood (2023) 142 (Supplement 1): 205.
https://doi.org/10.1182/blood-2023-177673
Published: 2023
Journal Articles

Dose/schedule-adjusted Rd-R vs continuous Rd for elderly, intermediate-fit patients with newly diagnosed multiple myeloma

Clinical Trials & Observations
Alessandra Larocca, Francesca Bonello, Gianluca Gaidano, Mattia D’Agostino, Massimo Offidani, Nicola Cascavilla, Andrea Capra, Giulia Benevolo, Patrizia Tosi, Monica Galli, Roberto Marasca, Nicola Giuliani, Annalisa Bernardini, Elisabetta Antonioli, Delia Rota-Scalabrini, Claudia Cellini, Alessandra Pompa, Federico Monaco, Francesca Patriarca, Tommaso Caravita di Toritto, Paolo Corradini, Paola Tacchetti, Mario Boccadoro, Sara Bringhen
Journal: Blood
Blood (2021) 137 (22): 3027–3036.
https://doi.org/10.1182/blood.2020009507
Published: 2021
Includes: Supplemental data
Journal Articles

Efficacy and Safety of Ixazomib Induction and Maintenance in Newly Diagnosed Multiple Myeloma Patients According to the IMWG Frailty Score: A Post-Hoc Analysis of the EMN10-Unito Trial

Roberto Mina, MD, Alessandra Larocca, Massimo Offidani, Vanessa Innao, Claudia Cellini, Monica Galli, Giusy Cetani, Mariella Grasso, Giovannino Ciccone, Andrea Capra, Sara Aquino, Claudia Priola, Gloria Margiotta Casaluci, Giovanni De Sabbata, Stelvio Ballanti, Michele Cavo, Mario Boccadoro, Sara Bringhen, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 44–45.
https://doi.org/10.1182/blood-2020-136292
Published: 2020
Journal Articles

Impact of Gain and Amplification of 1q in Newly Diagnosed Multiple Myeloma Patients Receiving Carfilzomib-Based Treatment in the Forte Trial

Mattia D'Agostino, MD, Marina Ruggeri, Sara Aquino, Nicola Giuliani, Maddalena Arigoni, Massimo Gentile, Martina Olivero, Iolanda Donatella Vincelli, Andrea Capra, Chiara Mussatto, Antonio Ledda, Paola Tacchetti, Caterina Musolino, Claudia Cellini, Francesca Patriarca, Stelvio Ballanti, Raffaele Calogero, Pellegrino Musto, Mario Boccadoro, Francesca Gay, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 38–40.
https://doi.org/10.1182/blood-2020-137060
Published: 2020
Journal Articles

Sequential Matrix-RICE Therapy Followed By Autologous Stem Cell Transplant in Patients with Diffuse Large B-Cell Lymphoma and Secondary Central Nervous System Involvement: The International Extranodal Lymphoma Study Group-42 Phase II (MARIETTA) Trial

Andres JM Ferreri, MD, Jeanette K. Doorduijn, MD PhD, Chiara Cattaneo, MD, Maria Giuseppina Cabras, MD, Jeffery Smith, MBChB BMedSci MRCP FRCPath, Fiorella Ilariucci, Franco Narni, Teresa Calimeri, MD PhD, Alessandro Re, MD, Jahanzaib Khwaja, Barbara Botto, Claudia Cellini, MD, Luca Nassi, Kim Linton, MBChB PhD, Pam McKay, MD, Jacopo Olivieri, Caterina Patti, MD, Francesca Re, Alessandro Fanni, MD, Vikram Singh, MD, Jacoline Bromberg, MD, Kelly Cozens, Elisabetta Gastaldi, Nicola Cascavilla, Andrew Davies, MD PhD, Christopher P Fox, MBChB(Hons), MRCP, FRCPath, PhD, Maurizio Frezzato, MD, Wendy Osborne, MBBS, Anna Marina Liberati, Urban Novak, Renato Zambello, Emanuele Zucca, MD, Kate Cwynarski, PhDMD
Journal: Blood
Blood (2019) 134 (Supplement_1): 353.
https://doi.org/10.1182/blood-2019-129835
Published: 2019
Journal Articles

Tumor Circulating Plasma Cells Detected By Flow Cytometric Single Platform Method Correlate with Clinical Response to Therapy and Unfavorable Patients' Characteristics

Vittorio Emanuele Muccio, Milena Gilestro, Elona Saraci, Andrea Capra, Alessandro Costa, Marina Ruggeri, Simona Caltagirone, Daniela Oddolo, Chiara Mussatto, Pellegrino Musto, Lucia Pantani, Vincenzo Pavone, Sonia Ronconi, Iolanda Donatella Vincelli, Anna Maria Cafro, Claudia Cellini, Vanessa Innao, Eugenio Piro, Francesca Gay, MD, Mario Boccadoro, Paola Omedé
Journal: Blood
Blood (2019) 134 (Supplement_1): 4357.
https://doi.org/10.1182/blood-2019-122657
Published: 2019
Journal Articles

Efficacy and Safety of Ixazomib-Dexamethasone, Ixazomib-Cyclophosphamide-Dexamethasone, Ixazomib-Thalidomide-Dexamethasone and Ixazomib-Bendamustine-Dexamethasone for Elderly Newly Diagnosed Multiple Myeloma (NDMM) Patients: Analysis of the Phase II Randomized Unito-EMN10 Study

Alessandra Larocca, Paolo Corradini, Roberto Mina, Nicola Cascavilla, Anna Marina Liberati, Norbert Pescosta, Maria Teresa Petrucci, Giovannino Ciccone, Andrea Capra, Francesca Patriarca, Delia Rota Scalabrini, Vanessa Innao, Marco Poggiu, Michele Cea, Renato Zambello, Anna Baraldi, Angelo Belotti, Claudia Cellini, Monica Galli, Mariella Grasso, Sara Aquino, Gloria Margiotta Casaluci, Giovanni De Sabbata, Stelvio Ballanti, Massimo Offidani, Katia Mancuso, Mario Boccadoro, Sara Bringhen
Journal: Blood
Blood (2019) 134 (Supplement_1): 3195.
https://doi.org/10.1182/blood-2019-124388
Published: 2019
Journal Articles

Bortezomib-Thalidomide-Dexamethasone Versus Thalidomide-Dexamethasone before and after Double Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma: Final Analysis of Phase 3 Gimema-MMY-3006 Study and Prognostic Score for Survival Outcomes

Paola Tacchetti, MD PhD, Luca Dozza, MSc, Francesco Di Raimondo, MD, Claudia Crippa, MD, Elena Zamagni, MD, Sara Bringhen, MD, Lucia Pantani, MD, Massimo Offidani, MD, Vittorio Montefusco, MD, Franco Narni, MD, Katia Mancuso, MD, Claudia Cellini, MD, Antonio Spadano, MD, Norbert Pescosta, MD, Luca Baldini, MD, Carolina Terragna, Chiara Nozzoli, MD, Renato Zambello, MD, Daniele Derudas, MD, Stelvio Ballanti, MD, Michele Cavo, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 125.
https://doi.org/10.1182/blood-2018-99-116716
Published: 2018
Journal Articles

Efficacy and Feasibility of Dose/Schedule-Adjusted Rd-R Vs. Continuous Rd in Elderly and Intermediate-Fit Newly Diagnosed Multiple Myeloma (NDMM) Patients: RV-MM-PI-0752 Phase III Randomized Study

Alessandra Larocca, MD, Marco Salvini, MD, Lorenzo De Paoli, MD, Nicola Cascavilla, MD, Giulia Benevolo, MD, Monica Galli, MD, Vittorio Montefusco, MD, Tommaso Caravita di Toritto, MD, Anna Baraldi, MD, Stefano Spada, Nicola Giuliani, MD PhD, Chiara Pautasso, Stefano Pulini, MD, Sonia Ronconi, MD, Norbert Pescosta, MD, Anna Marina Liberati, MD, Francesca Patriarca, MD, Claudia Cellini, MD, Patrizia Tosi, MD, Massimo Offidani, MD, Michele Cavo, MD, Antonio Palumbo, MD, Mario Boccadoro, MD, Sara Bringhen, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 305.
https://doi.org/10.1182/blood-2018-99-111796
Published: 2018
Journal Articles

Bortezomib-Dexamethasone Re-Treatment at Biochemical Relapse Vs Observation in Relapsed/Refractory Multiple Myeloma Patients: Results of a Phase II Multi-Center, Randomized Study

Roberto Mina, MD, Alessandra Larocca, Angelo Belotti, MD, Francesco Di Raimondo, MD, Anna Baraldi, MD, Massimo Offidani, MD, Monia Marchetti, MD, Roberto Ria, MD, Annarita Conconi, MD, Norbert Pescosta, MD, Mariella Grasso, MD, Giusy Cetani, MD, Anna Maria Cafro, MD, Roberto Passera, Rossella Troia, Gianpietro Semenzato, MD, Nicola Giuliani, MD PhD, Stelvio Ballanti, MD, Claudia Cellini, MD, Anna Marina Liberati, Tommaso Caravita di Toritto, MD, Maria Teresa Petrucci, MD, Pellegrino Musto, MD, Antonio Palumbo, MD, Pieter Sonneveld, MDPhD, Mario Boccadoro, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3128.
https://doi.org/10.1182/blood.V130.Suppl_1.3128.3128
Published: 2017
Journal Articles

Bortezomib-Based Therapy Overcomes the Adverse Impact of Renal Impairment in Transplant Eligible Patients: An Analysis of the Prospective Randomized EMN02/HO95 Study

Meletios A. Dimopoulos, Efstathios Kastritis, Roman Hajek, Luca Dozza, Meral Beksac, MD, Alessandra Larocca, Hans Erik Johnsen, MD Professor, Ulf-Henrik Mellqvist, MD, Anders Waage, MD PhD, Sonja Zweegman, MD PhD, Heinz Ludwig, MD, Lucia Pantani, MD, Andrew Spencer, MD, Anna Pascarella, Marina Martello, Susana Carvalho, Hlif Steingrimsdottir, MD, Claudia Cellini, MD, Petra Cornelisse, Rossella Troia, Patrizia Tosi, MD, Bronno van der Holt, Mario Boccadoro, Pieter Sonneveld, MDPhD, Michele Cavo, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4545.
https://doi.org/10.1182/blood.V130.Suppl_1.4545.4545
Published: 2017
Journal Articles

The Combination of Frailty and ISS Scores Identifies a Simple Prognostic Index for Overall Survival in Elderly Patients Treated with Novel Agents-Based Induction Therapy

Alessandra Larocca, MD, Sara Bringhen, MD, Roman Hajek, Maria Teresa Petrucci, MD, Massimo Offidani, MD, Roberto Mina, MD, Vittorio Montefusco, MD, Gabriele Aitoro, MD, Claudia Cellini, MD, Enrico Maria Pogliani, MD, Lorenzo De Paoli, Marina Ruggeri, Laura Maracci, MD, Oreste Villani, MD, Chiara Nozzoli, MD, Alessia La Fauci, MD, Marta Chisini, MD, Francesca Gay, MD, Roberto Marasca, MD, Stelvio Ballanti, MD, Nicola Giuliani, MD PhD, Pellegrino Musto, MD, Mario Boccadoro, MD, Pieter Sonneveld, MDPhD, Antonio Palumbo, MD
Journal: Blood
Blood (2014) 124 (21): 4740.
https://doi.org/10.1182/blood.V124.21.4740.4740
Published: 2014
Journal Articles

Bendamustine, Bortezomib and Dexamethasone (BVD) in Patients with Relapsed-Refractory Multiple Myeloma (MM): Updated Results of a Multicenter Phase II Study

Massimo Offidani, MD, Laura Maracci, Laura Corvatta, Liberati Anna Marina, Stelvio Ballanti, MD, Imma Attolico, Patrizia Caraffa, Francesco Alesiani, Tommaso Caravita di Toritto, Silvia Gentili, Patrizia Tosi, Marino Brunori, Daniele Derudas, MD, Antonio Ledda, Alessandro Gozzetti, Claudia Cellini, MD, Lara Malerba, Anna Mele, Stefano Felici, Sara Galimberti, MD PhD, Patrizia Mondello, Stefano Pulini, Ugo Coppetelli, Paolo Fraticelli, Rita Rizzi, Pietro Leoni
Journal: Blood
Blood (2014) 124 (21): 4734.
https://doi.org/10.1182/blood.V124.21.4734.4734
Published: 2014
Journal Articles

Virtual Karyotype Reconstruction By SNPs Array of Newly Diagnosed Multiple Myeloma (MM) Patients Enrolled in the EMN02 Clinical Trial

Carolina Terragna, PhD, Angela Flores Dico, Marina Martello, PhD, Vincenzo Callea, MD, Gioacchino Catania, MD, Tonino Spadano, MD, Tommaso Caravita di Toritto, Nicoletta Testoni, BSc, Anders Waage, MD PhD, Enrica Borsi, PhD, Antonio Palumbo, MD, Sonja Zweegman, MD PhD, Annamaria Cafro, MD, Angelo D. Palmas, MD, Silvestro Volpe, MD, Marcella Prete, MD, Ernesto Vigna, MD, Luca De Rosa, MD, Claudia Cellini, MD, Pieter Sonneveld, MD, Michele Cavo, MD
Journal: Blood
Blood (2014) 124 (21): 2033.
https://doi.org/10.1182/blood.V124.21.2033.2033
Published: 2014
Journal Articles

Bendamustine, Bortezomib and Dexamethasone (BVD): A Combination With a Substantial Activity and a Manageable Toxicity In Patients With Relapsed-Refractory Multiple Myeloma (MM)

Massimo Offidani, Laura Corvatta, Laura Maracci, Anna Marina Liberati, Stelvio Ballanti, Immacolata Attolico, Patrizia Caraffa, Francesco Alesiani, Tommaso Caravita di Toritto, Silvia Gentili, Patrizia Tosi, Marino Brunori, Daniele Derudas, MD, Antonio Ledda, Alessandro Gozzetti, Claudia Cellini, Lara Malerba, Anna Mele, Alessandro Andriani, Sara Galimberti, Patrizia Mondello, Stefano Pulini, Ugo Coppetelli, Paolo Fraticelli, Attilio Olivieri, Pietro Leoni
Journal: Blood
Blood (2013) 122 (21): 1974.
https://doi.org/10.1182/blood.V122.21.1974.1974
Published: 2013
Journal Articles

Bortezomib-Thalidomide-Dexamethasone Incorporated Into Autotransplantation Is Associated with More Favorable Outcomes After Relapse in Comparison with Thalidomide-Dexamethasone Plus Autotransplantation in Multiple Myeloma

Michele Cavo, MD, Monica Galli, MD, Lucia Pantani, MD, Francesco Di Raimondo, MD, Claudia Crippa, MD, Massimo Offidani, MD, Elena Zamagni, MD, Vittorio Montefusco, MD, Franco Narni, MD, Annalisa Pezzi, Antonio Spadano, MD, Norbert Pescosta, MD, Paola Tacchetti, MD, Luca Baldini, MD, Antonio Ledda, MD, Claudia Cellini, MD, Tommaso Caravita, MD, Antonietta Falcone, MD, Chiara Nozzoli, MD, Renato Zambello, MD, Luciano Masini, MD, Mario Boccadoro, MD
Journal: Blood
Blood (2012) 120 (21): 4210.
https://doi.org/10.1182/blood.V120.21.4210.4210
Published: 2012
Journal Articles

Ten Year-Long Term Survival After up-Front Autologous Stem Cell Transplantation in Multiple Myeloma: Results From Two Prospective Clinical Trials

Elena Zamagni, MD, Francesco Di Raimondo, MD, Francesca Patriarca, Patrizia Tosi, Annalisa Pezzi, Claudia Cellini, Paola Tacchetti, MD, Sonia Ronconi, Silvestro Volpe, Lucia Pantani, MD, Lucio Catalano, Mauro Fiacchini, Emanuele Angelucci, Luciano Masini, Alessandro Gozzetti, Piero Galieni, Beatrice Zannetti, Franco Narni, Annamaria Brioli, Carolina Terragna, PhD, Antonio Lazzaro, Katia Mancuso, Catello Califano, Antonio Ledda, Nicoletta Testoni, Michele Baccarani, MD, Michele Cavo, MD
Journal: Blood
Blood (2012) 120 (21): 594.
https://doi.org/10.1182/blood.V120.21.594.594
Published: 2012